SEATTLE -- A new botulinum toxin formulation kept cervical dystonia symptoms down for a solid 16 weeks in most patients treated in a manufacturer-sponsored phase III trial, a researcher said here.

The US Food and Drug Administration (FDA) has expanded the indiction for daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) for the treatment of cervical dystonia in adults, the ...

An artificial intelligence tool called DystoniaBoTXNet predicted which patients with dystonia would benefit from botulinum toxin injections with 96.3% accuracy. DystoniaBoTXNet could be a tool to aid ...

About Cervical Dystonia According to the Dystonia Medical Research Foundation, cervical dystonia is a painful condition in which the neck muscles contract involuntarily, causing abnormal movements and ...

A Columbia resident with cervical dystonia, a chronic and painful disorder causing involuntary spasms of neck muscles, won a national contest that will award $10,000 to the Bethesda Naval Hospital to ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC) a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that it has submitted a ...

Q: I was diagnosed with dystonia two years ago. It affects my left leg and left hand. My neurologist has had me on a number of medications, including Nadolol, Klonopin, Topamax and Neurontin. I am ...

Shares of Revance Therapeutics Inc. RVNC gained 8% premarket on Monday after the U.S. Food and Drug Administration approved the biotech company’s Daxxify injection for treatment of cervical dystonia ...

Revance Therapeutics' share price has been characterised by volatility ever since its IPO - but today shares trade close to an all-time low. The company's focus is on maximising the potential of ...

In February 2008, the FDA issued an "Early Communication about an Ongoing Safety Review: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)" which stated: "This ...